Annual Working Capital
$451.82 M
-$52.38 M-10.39%
December 31, 2024
Summary
- As of March 3, 2025, MLTX annual working capital is $451.82 million, with the most recent change of -$52.38 million (-10.39%) on December 31, 2024.
- During the last 3 years, MLTX annual working capital has risen by +$463.28 million (+4045.76%).
- MLTX annual working capital is now -10.39% below its all-time high of $504.20 million, reached on December 31, 2023.
Performance
MLTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$451.82 M
-$40.41 M-8.21%
December 31, 2024
Summary
- As of March 3, 2025, MLTX quarterly working capital is $451.82 million, with the most recent change of -$40.41 million (-8.21%) on December 31, 2024.
- Over the past year, MLTX quarterly working capital has dropped by -$40.41 million (-8.21%).
- MLTX quarterly working capital is now -17.05% below its all-time high of $544.68 million, reached on March 31, 2024.
Performance
MLTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
MLTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.4% | -8.2% |
| 3 y3 years | +4045.8% | +662.9% |
| 5 y5 years | +4045.8% | +662.9% |
MLTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.4% | +4045.8% | -17.1% | +4045.8% |
| 5 y | 5-year | -10.4% | +4045.8% | -17.1% | +4045.8% |
| alltime | all time | -10.4% | +4045.8% | -17.1% | +4045.8% |
MoonLake Immunotherapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $451.82 M(-10.4%) | $451.82 M(-8.2%) |
| Sep 2024 | - | $492.24 M(-6.2%) |
| Jun 2024 | - | $524.60 M(-3.7%) |
| Mar 2024 | - | $544.68 M(+8.0%) |
| Dec 2023 | $504.20 M | $504.20 M(+3.0%) |
| Sep 2023 | - | $489.70 M(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $499.23 M(+742.9%) |
| Mar 2023 | - | $59.23 M(-14.0%) |
| Dec 2022 | $68.85 M(-701.2%) | $68.85 M(-16.6%) |
| Sep 2022 | - | $82.52 M(-12.7%) |
| Jun 2022 | - | $94.52 M(-925.4%) |
| Dec 2021 | -$11.45 M | -$11.45 M |
FAQ
- What is MoonLake Immunotherapeutics annual working capital?
- What is the all time high annual working capital for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual working capital year-on-year change?
- What is MoonLake Immunotherapeutics quarterly working capital?
- What is the all time high quarterly working capital for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly working capital year-on-year change?
What is MoonLake Immunotherapeutics annual working capital?
The current annual working capital of MLTX is $451.82 M
What is the all time high annual working capital for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual working capital is $504.20 M
What is MoonLake Immunotherapeutics annual working capital year-on-year change?
Over the past year, MLTX annual working capital has changed by -$52.38 M (-10.39%)
What is MoonLake Immunotherapeutics quarterly working capital?
The current quarterly working capital of MLTX is $451.82 M
What is the all time high quarterly working capital for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly working capital is $544.68 M
What is MoonLake Immunotherapeutics quarterly working capital year-on-year change?
Over the past year, MLTX quarterly working capital has changed by -$40.41 M (-8.21%)